Life Sciences Tools and Services
Company Overview of STEMCELL Technologies, Inc.
STEMCELL Technologies, Inc., a biotechnology company, develops specialty cell culture media, cell separation products, and ancillary reagents for life science research applications. The company provides cell isolation products, antibodies, primary cells, mammalian cloning products, small molecules, cryopreservation media, cytokines, cell culture substrates and matrices, other cell culture media, reagents and supplies, instruments, software, stem cell detection kits, and proficiency testing solutions. Its cell types include B, brain tumor stem, bronchial epithelial, CHO, and dendritic cells; and embryonic stem and iPS cells (human), embryonic stem cells and iPS cells (mouse), granulocytes and...
570 West Seventh Avenue
Vancouver, BC V5Z 1B3
Founded in 1993
Key Executives for STEMCELL Technologies, Inc.
Chief Executive Officer and President
Compensation as of Fiscal Year 2016.
STEMCELL Technologies, Inc. Key Developments
STEMCELL Technologies, Inc. to Test the Evo Smart Shipper and Cloud Based Biologistex Cold Chain Management App
Jan 6 16
BioLife Solutions, Inc. announced that STEMCELL Technologies will test BioLife's evo Smart Shipper and biologistex cold chain SaaS on a variety of temperature sensitive products for research in areas such as cellular therapies, blood cancers, and solid tumors. BioLife's biologistex cloud based cold chain management service is a new integrated logistics and track and trace web app used by shippers of time and temperature sensitive biologic materials. The evo Smart Shipper is a precision thermal shipping container with embedded payload monitoring, GPS location tracking, and cellular communication electronics that transmit critical shipment information to the cloud. This SaaS app enables users to monitor high value shipments during transit and configure actionable alerts for downstream recipients for location, approaching destination, delivery, package open, and remaining shelf life or stability via the patent pending StableAlert™ countdown timer.
STEMCELL Technologies, Inc. Presents at BIO-Europe 2015, Nov-02-2015
Oct 9 15
STEMCELL Technologies, Inc. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.
STEMCELL Technologies Inc Launches Innovative Products to Support CAR T Cell Research
Jun 30 15
STEMCELL Technologies Inc. announced the launch of ImmunoCult Human T Cell Activator reagents and ImmunoCult -XF T Cell Expansion Medium to support T cell researchers in their goal to develop CAR T cell immunotherapeutics. The products provide significant benefits compared to existing technologies. ImmunoCult Human T Cell Activators are soluble reagents that elicit robust activation and expansion of T cells and are highly shelf-stable. The Activator reagents are optimized for use with the xeno- and serum-free ImmunoCult -XF T Cell Expansion Medium. Together, ImmunoCult T Cell Activator reagents and ImmunoCult -XF T Cell Expansion Medium promote a streamlined workflow for the ex vivo activation and expansion of human T cells. ImmunoCult Human T Cell Activator reagents and ImmunoCult -XF T Cell Expansion Medium build on STEMCELL’s existing portfolio of products to support T cell research, including the EasySep product line for immunomagnetic isolation of T cells. The new ImmunoCult products are currently for research use and STEMCELL is looking for partners to develop them for clinical applications.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|